Cutler Group’s Larimar Therapeutics LRMR Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2024
Q1 | – | Sell |
-400
| Closed | -$1K | – | 1424 |
|
|
2023
Q4 | $1K | Hold |
400
| – | – | ﹤0.01% | 1229 |
|
|
2023
Q3 | $1K | Sell |
400
-400
| -50% | -$1K | ﹤0.01% | 1317 |
|
|
2023
Q2 | $2K | Hold |
800
| – | – | ﹤0.01% | 1232 |
|
|
2023
Q1 | $3K | Sell |
800
-200
| -20% | -$750 | ﹤0.01% | 1207 |
|
|
2022
Q4 | $4K | Hold |
1,000
| – | – | ﹤0.01% | 1465 |
|
|
2022
Q3 | $3K | Sell |
1,000
-200
| -17% | -$600 | ﹤0.01% | 1665 |
|
|
2022
Q2 | $2K | Hold |
1,200
| – | – | ﹤0.01% | 1716 |
|
|
2022
Q1 | $4K | Hold |
1,200
| – | – | ﹤0.01% | 1720 |
|
|
2021
Q4 | $12K | Buy |
+1,200
| New | +$12K | ﹤0.01% | 1620 |
|
|
2021
Q3 | – | Hold |
0
| – | – | – | 2470 |
|
|
2021
Q2 | – | Hold |
0
| – | – | – | 2479 |
|
|
2019
Q1 | – | Sell |
-8
| Closed | – | – | 1895 |
|
|
2018
Q4 | $0 | Sell |
8
-9
| -53% | – | ﹤0.01% | 1951 |
|
|
2018
Q3 | $2K | Buy |
17
+9
| +113% | +$1.06K | ﹤0.01% | 1481 |
|
|
2018
Q2 | $1K | Hold |
8
| – | – | ﹤0.01% | 1579 |
|
|
2018
Q1 | $0 | Hold |
8
| – | – | ﹤0.01% | 2184 |
|
|
2017
Q4 | $0 | Hold |
8
| – | – | ﹤0.01% | 2523 |
|
|
2017
Q3 | $0 | Hold |
8
| – | – | ﹤0.01% | 2823 |
|
|
2017
Q2 | $0 | Hold |
8
| – | – | ﹤0.01% | 3080 |
|
|
2017
Q1 | $0 | Sell |
8
-390
| -98% | – | ﹤0.01% | 3123 |
|
|
2016
Q4 | $15K | Buy |
398
+15
| +4% | +$565 | ﹤0.01% | 2039 |
|
|
2016
Q3 | $15K | Buy |
383
+266
| +227% | +$10.4K | ﹤0.01% | 1952 |
|
|
2016
Q2 | $8K | Sell |
117
-217
| -65% | -$14.8K | ﹤0.01% | 2235 |
|
|
2016
Q1 | $26K | Sell |
334
-118
| -26% | -$9.19K | ﹤0.01% | 1605 |
|
|
2015
Q4 | $34K | Buy |
+452
| New | +$34K | ﹤0.01% | 1595 |
|